Buy Trovagene Stock | TROV Stock Price & Latest News | Public
TROV

Trovagene

$0.00 (0.00%)Today

    About TROV

    Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.34
    -0.51
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.23

    Actual EPS
    Q3 2020

    Stats

    Market Cap$284,5M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.30
    1 Year Low$0.70
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app